Ultragenyx Pharmaceutical Inc. has announced the grant of 44,805 restricted stock units to 20 newly hired non-executive officers as part of their Ultragenyx Employment Inducement Plan. Approved by the company's compensation committee, these awards are intended as inducement material for new employees joining the company. The grant date for these stock units is May 16, 2025, and they will vest over a period of four years. Specifically, 25% of the shares will vest on each anniversary of the grant date, provided the employee remains continuously employed with Ultragenyx. This plan is in accordance with Nasdaq Listing Rule 5635(c)(4).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.